Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP) (original) (raw)

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

Gut, 1985

Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication

Nathalie Boyer

Gut, 1995

View PDFchevron_right

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

Harry Greenberg

Antimicrobial Agents and Chemotherapy, 1982

View PDFchevron_right

Original Articles Adenine Arabinoside Monophosphate Coupled to Lactosaminated Human Albumin Administered for 4 Weeks in Patients With Chronic Type B Hepatitis Decreased Viremia Without Producing Significant Side Effects

antonio ponzetto

View PDFchevron_right

One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b

G. Krejs

Journal of Hepatology, 1990

View PDFchevron_right

Failure of acyclovir to enhance the antiviral effect of α lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B

R. Deman

Journal of Hepatology, 1992

View PDFchevron_right

Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects

Luigi Fiume, Ferruccio Bonino, antonio ponzetto

Hepatology (Baltimore, Md.), 1996

View PDFchevron_right

Adenine Arabinoside Monophosphate Coupled to Lactosaminated Human Albumin....Chronic Type B Hepatitis Decreased

Antonio Ponzetto, Luigi Fiume

View PDFchevron_right

Kronik Hepatit B\'li Hastalarda Pegile-İnterferon Alfa-2a ve Alfa-2b\'nin Kromozomal Düzensizlikler ve Mitotik İndeks Üzerine Etkileri

Halit Akbaş

Turkiye Klinikleri Journal of Medical Sciences, 2012

View PDFchevron_right

Risks and Benefits of Interferon-α in the Treatment of Hepatitis

Juan David Quiroga

Drug Safety, 1995

View PDFchevron_right

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

Iain M. Murray-Lyon

BMJ, 1989

View PDFchevron_right

Comparative effects of α, β and γ human interferons on a HBsAg-producing human hepatoma cell line

Paola Pauri

La Ricerca in Clinica e in Laboratorio, 1986

View PDFchevron_right

Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma

Guangwen Cao

World journal of virology, 2012

View PDFchevron_right

Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy

Ching-Lung Lai

Hepatology, 2013

View PDFchevron_right

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha

Osamu Yokosuka

Digestive Diseases and Sciences, 1989

View PDFchevron_right

Treatment of chronic hepatitis B: New antiviral therapies

Robert Gish

Current Gastroenterology Reports, 1999

View PDFchevron_right

A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis

Giorgio Saracco

Journal of Hepatology, 1990

View PDFchevron_right

Recombinant-α2b-interferon treatment in patients with chronic active hepatitis: effects on peripheral blood mononuclear cells and correlation with response

Franca Lazzari

Current Therapeutic Research, 1995

View PDFchevron_right

Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver

Johnson Lau

Gastroenterology

View PDFchevron_right

The risk of de novo hepatocellular carcinoma still exists in the in the direct acting antiviral era

Mohamed Shoreibah

AME Medical Journal, 2018

View PDFchevron_right

Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV

Denis Ouzan

Journal of Hepatology, 1986

View PDFchevron_right

HD 03 ES Antiviral Research 2009

pralhad patki

View PDFchevron_right

Effects of antiviral agents on chronic hepatitis B

Osamu Yokosuka

Digestive Diseases and Sciences, 1992

View PDFchevron_right

Inhibition of HBV gene expression and replication by stably expressed interferon-α1 via adeno-associated viral vectors

Hong Yao

The Journal of Gene Medicine, 2008

View PDFchevron_right

Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B

Jaime Guardia

Liver, 1993

View PDFchevron_right

Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B

Hideaki Takahashi, Kotaro Matsunaga

Hepatology Research, 2010

View PDFchevron_right

Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of …

Jaime Guardia

Journal of hepatology

View PDFchevron_right

Treatment of chronic delta hepatitis with α-2 recombinant interferon

Ferruccio Bonino

Journal of Hepatology, 1986

View PDFchevron_right

The decrease of HBsAg during nucleos(t)ide analogues (NUC) therapy in Bulgarian patients

Zahariy Krastev

Biotechnology & Biotechnological Equipment, 2015

View PDFchevron_right

Recombinant Human Interferon- Inhibits Adenovirus Multiplication in Vitro

Roberto Diez

Journal of General Virology, 1987

View PDFchevron_right

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Hakan Senturk

The Lancet, 2005

View PDFchevron_right

EFFECTS OF INTERFERON-ALFA-2a ON HUMAN HEPATOMA HepG2 CELLS

Sami Kartí

Experimental …, 2003

View PDFchevron_right

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

Teerha Piratvisuth

New England Journal of Medicine, 2005

View PDFchevron_right

Comparison of lamivudine -α-interferon combination and α-interferon alone treatments in adult patients with naive HBeAg negative hepatitis B

Habibe Çolak, Celal Ayaz

View PDFchevron_right

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for …

C. Trepo

… England Journal of …, 1998

View PDFchevron_right

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP) (original) (raw)

Related papers